Select a metric from the list below to chart it
Feb '20
Jan '21
Jan '22
Jan '23
LTM
Metric | Feb '20 | Jan '21 | Jan '22 | Jan '23 | LTM |
|---|---|---|---|---|---|
Total Revenues | 119.9 | 249.9 | 428.3 | 652.5 | 780.0 |
Total Revenues % Chg. | — | 108.5% | 71.4% | 52.3% | 45.6% |
Cost of Goods Sold, Total | 48.3 | 75.4 | 124.5 | 182.7 | 215.1 |
Gross Profit | 71.5 | 174.5 | 303.9 | 469.9 | 564.9 |
Selling General & Admin Expenses, Total | 228.9 | 277.5 | 451.1 | 540.9 | 604.9 |
R&D Expenses | 70.5 | 99.7 | 205.1 | 187.4 | 228.9 |
Other Operating Expenses | — | — | — | — | 0.1 |
Other Operating Expenses, Total | 299.4 | 377.2 | 656.2 | 728.3 | 833.9 |
Operating Income | -227.8 | -202.7 | -352.3 | -258.4 | -269.0 |
Interest And Investment Income | 2.9 | — | — | 15.6 | 33.3 |
Net Interest Expenses | 2.9 | — | — | 15.6 | 33.3 |
Other Non Operating Income (Expenses) | — | -0.6 | -0.0 | — | — |
EBT, Excl. Unusual Items | -224.9 | -203.4 | -352.3 | -242.8 | -235.8 |
Restructuring Charges | — | -6.8 | — | — | — |
Asset Writedown | — | — | -1.5 | -1.1 | -1.1 |
Other Unusual Items | — | — | — | — | 1.1 |
EBT, Incl. Unusual Items | -224.9 | -210.1 | -353.9 | -243.8 | -235.8 |
Income Tax Expense | 0.3 | 0.1 | 1.2 | 3.6 | 4.2 |
Earnings From Continuing Operations | -225.2 | -210.2 | -355.0 | -247.4 | -240.0 |
Net Income | -225.2 | -210.2 | -355.0 | -247.4 | -240.0 |
Preferred Dividend and Other Adjustments | — | 9.6 | — | — | — |
Net Income to Common Incl Extra Items | -225.2 | -219.8 | -355.0 | -247.4 | -240.0 |
Net Income to Common Excl. Extra Items | -225.2 | -219.8 | -355.0 | -247.4 | -240.0 |
Total Shares Outstanding | 241.2 | 246.0 | 505.5 | 524.2 | 534.9 |
Weighted Avg. Shares Outstanding | 230.4 | 239.3 | 277.5 | 514.3 | 524.1 |
Weighted Avg. Shares Outstanding Dil | 230.4 | 239.3 | 277.5 | 514.3 | 524.1 |
EPS | -1.0 | -0.9 | -1.3 | -0.5 | -0.5 |
EPS Diluted | -1.0 | -0.9 | -1.3 | -0.5 | -0.5 |
EBITDA | -225.6 | -194.8 | -345.3 | -250.5 | -259.2 |